Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality

Fardad Haghpanah, Gary Lin, Simon A. Levin, Eili Klein

Research output: Contribution to journalArticlepeer-review

29 Scopus citations


Background: COVID-19 vaccines have been approved and made available. While questions of vaccine allocation strategies have received significant attention, important questions remain regarding the potential impact of the vaccine given uncertainties regarding efficacy against transmission, availability, timing, and durability. Methods: We adapted a susceptible-exposed-infectious-recovered (SEIR) model to examine the potential impact on hospitalization and mortality assuming increasing rates of vaccine efficacy, coverage, and administration. We also evaluated the uncertainty of the vaccine to prevent infectiousness as well as the impact on outcomes based on the timing of distribution and the potential effects of waning immunity. Findings: Increased vaccine efficacy against disease reduces hospitalizations and deaths from COVID-19; however, the relative benefit of transmission blocking varied depending on the timing of vaccine distribution. Early in an outbreak, a vaccine that reduces transmission will be relatively more effective than one introduced later in the outbreak. In addition, earlier and accelerated implementation of a less effective vaccine is more impactful than later implementation of a more effective vaccine. These findings are magnified when considering the durability of the vaccine. Vaccination in the spring will be less impactful when immunity is less durable. Interpretation: Policy choices regarding non-pharmaceutical interventions, such as social distancing and face mask use, will need to remain in place longer if the vaccine is less effective at reducing transmission or distributed slower. In addition, the stage of the local outbreak greatly impacts the overall effectiveness of the vaccine in a region and should be considered when allocating vaccines. Funding: Centers for Disease Control and Prevention (CDC) MInD-Healthcare Program (U01CK000589, 1U01CK000536), James S. McDonnell Foundation 21st Century Science Initiative Collaborative Award in Understanding Dynamic and Multiscale Systems, National Science Foundation (CNS-2027908), National Science Foundation Expeditions (CCF1917819), Digital Transformation Institute (AWD1006615), and Google, LLC.

Original languageEnglish (US)
Article number100863
StatePublished - May 2021

All Science Journal Classification (ASJC) codes

  • General Medicine


  • COVID-19
  • SARS-CoV-2
  • efficacy
  • morbidity
  • mortality
  • scenario
  • vaccine


Dive into the research topics of 'Analysis of the potential impact of durability, timing, and transmission blocking of COVID-19 vaccine on morbidity and mortality'. Together they form a unique fingerprint.

Cite this